Endogenous IL-32 controls cytokine and HIV-1 production

Journal of Immunology

Volumn 181, Issue 1, 2008, Pages 557-565

  Nold, Marcel F ^a,b   Nold Petry, Claudia A ^a   Pott, Gregory B ^a   Zepp, Jarod A ^a   Saavedra, Milene T ^a   Kim, Soo Hyun ^a,b   Dinarello, Charles A ^a,c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c Konkuk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; GAG PROTEIN; GAMMA INTERFERON; INTERLEUKIN 32; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN DERIVATIVE; P24 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; MACROPHAGE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VIRUS INHIBITION; BIOSYNTHESIS; CELL CULTURE; GENETICS; METABOLISM; PROTEIN BINDING; UPREGULATION;

ANTI-HIV AGENTS; CELLS, CULTURED; CYTOKINES; DNA; HIV CORE PROTEIN P24; HIV-1; HUMANS; INTERLEUKINS; NF-KAPPA B; PROTEIN BINDING; RNA, SMALL INTERFERING; TRANSCRIPTION FACTOR AP-1; UP-REGULATION;

EID: 47949093903     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.1.557     Document Type: Article

References (50)

1. Dahl, C. A., R. P. Schall, H. L. He, and J. S. Cairns. 1992. Identification of a novel gene expressed in activated natural killer cells and T cells. J. Immunol. 148: 597-603.
2. Kim, S. H., S. Y. Han, T. Azam, D. Y. Yoon, and C. A. Dinarello. 2005. Inter-Ieukin-32: a cytokine and inducer of TNFα. Immunity 22: 131-142.
3. Goda, C., T. Kanaji, S. Kanaji, G. Tanaka, K. Arima, S. Ohno, and K. Izuhara. 2006. Involvement of IL-32 in activation-induced cell death in T cells. lnt. Immunol. 18: 233-240.
4. Netca, M. G., T. Azam, E. C. Lewis, L. A. Joosten, M. Wang, D. Langenberg, X. Meng, E. D. Chan, D. Y. Yoon, T. Ottenhoff, et al. 2006. Mycobacterium tuberculosis induces interleukin-32 production through a caspase-1/IL-18/inter-feron-γ-dependent mechanism. PLoS Med. 3: e277.
5. Novick, D., M. Rubinstein, T. Azam, A. Rabinkov, C. A. Dinarello, and S. H. Kim. 2006. Proteinase 3 is an IL-32 binding protein. Proc. Natl. Acad. Sci. USA 103: 3316-3321.
6. Netea, M. G., T. Azam, G. Ferwerda, S. E. Girardin, M. Walsh, J. S. Park, E. Abraham, J. M. Kim, D. Y. Yoon, C. A. Dinarello, and S. H. Kim. 2005. IL-32 synergizes with nucleotide oligomerization domain (NOD) I and NOD2 ligands for IL-1β and IL-6 production through a caspase 1-dependent mechanism. Proc. Natl. Acad. Sci. USA 102: 16309-16314.
7. Shoda, H., K. Fujio, Y. Yamaguchi, A. Okamoto, T. Sawada, Y. Kochi, and K. Yamamoto. 2006. Interactions between IL-32 and tumor necrosis factor α contribute to the exacerbation of immune-inflammatory diseases. Arthritis Res. Ther. 8: R166.
8. Shioya, M., A. Nishida, Y. Yagi, A. Ogawa, T. Tsujikawa, S. Kim-Milsuyama, A. Takayanagi, N. Shimizu, Y. Fujiyama, and A. Andoh. 2007. Epithelial over-expression of interleukin-32α in inflammatory bowel disease. Clin. Exp. Immunol. 149: 480-486.
9. Dinarello, C. A., and S. H. Kim. 2006. IL-32, a novel cytokine with a possible role in disease. Ann. Rheum. Dis. 65 (Suppl. 3): iii61-iii64.
10. Cagnard, N., F. Lelourneur, A. Essabbani, V. Devauchelle, S. Mistou, A. Rapinat, C. Decraene, C. Foumicr, and G. Chiocchia. 2005. Interleukin-32, CCL2, PF4F1, and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes. Eur. Cytokine Network 16: 289-292.
11. Joosten, L. A., M. G. Netea, S. II. Kim, D. Y. Yoon, B. Oppers-Walgreen, T. R. Radstake, P. Barrera, F. A. van de Loo, C. A. Dinarello, and W. B. van den Berg. 2006. IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 103: 3298-3303.
12. Edwards, C. J., J. L. Feldman, J. Beech, K. M. Shields, J. A. Stover, W. L. Trepicchio, G. Larscn, B. M. Foxwell, F. M. Brennan, M. Feldmann, and D. D. Pittman. 2007. Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritis. Mol. Med. 13: 40-58.
13. Palella, F. J., Jr., K. M. Delaney, A. C. Moorman, M. O. Loveless, J. Fuhrer, G. A. Satten, D. J. Aschman, and S. D. Holmberg. 1998. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection: HIV outpatient study investigators. N. Engl. J. Med. 338: 853-860.
14. Poli, G., A. L. Kinter, E. Vicenzi, and A. S. Fauci. 1994. Cytokine regulation of acute and chronic HIV infection in vitro: from cell lines to primary mononuclear cells. Res. Immunol. 145: 578-582.
15. Shapiro, L., K. A. Heidenreich, M. K. Meintzer, and C. A. Dinarello. 1998. Role of p38 mitogen-activated protein kinase in HIV type 1 production in vitro. Proc. Natl. Acad. Sci. USA 95: 7422-7426.
16. Folks, T. M., J. Justement, A. Kinter, C. A. Dinarello, and A. S. Fauci. 1987. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 238: 800-802.
17. Folks, T. M., J. Justement, A. Kinter, S. Schnittman, J. Orenstein, G. Poli, and A. S. Fauci. 1988. Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. J. Immunol. 140: 1117-1122.
18. Poli, G., A. L. Kinter, and A. S. Fauci. 1994. Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist. Proc. Natl. Acad. Sci. USA 91: 108-112.
19. Poli, G., A. Kinter, J. S. Justement, J. H. Kehrl, P. Bressler, S. Stanley, and A. S. Fauci. 1990. Tumor necrosis factor α functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc. Natl. Acad. Sci. USA 87: 782-785.
20. Shapiro, L., A. J. Puren, H. A. Barton, D. Novick, R. L. Peskind, R. Shenkar, Y. Gu, M. S. Su, and C. A. Dinarello. 1998. Interleukin 18 stimulates HIV type 1 in monocytic cells. Proc. Natl. Acad. Sci. USA 95: 12550-12555.
21. Choi, H. J., C. A. Dinarello, and L. Shapiro. 2001. Interleukin-18 inhibits human immunodeficiency virus type 1 production in peripheral blood mononuclear cells. J. Infect. Dis. 184: 560-568.
22. Petry, C., G. Fritz, J. Pfeilschifter, and A. Huwiler. 2004. Inhibition of Rho modulates cylokine-induced prostaglandin E2 formation in renal mesangial cells. Biochim. Biophys. Acta 1636: 108-118.
23. Novick, D., D. G. Fischer, Z. Reiter, Z. Eshhar, and M. Rubinstein. 1989. Monoclonal antibodies to the human interferon-γ receptor: blocking of the biological activities of interferon-γ and purification of the receptor. J. Interferon Res. 9: 315-328.
24. Kedzierska, K., and S. M. Crowe. 2001. Cytokines and HIV-1: interactions and clinical implications. Antiviral Chem. Chemother. 12: 133-150.
25. Butera, S. T. 1993. Cytokine involvement in viral permissiveness and the progression of HIV disease. J. Cell. Biochem. 53: 336-342.
26. Roux, P., C. Alfieri, M. Hrimech, E. A. Cohen, and J. E. Tanner. 2000. Activation of transcription factors NF-κB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression. J. Virol. 74:4658-4665.
27. Lane, B. R., K. Lore, P. J. Bock, J. Andersson, M. J. Coffey, R. M. Strieter, and D. M. Markovitz. 2001. Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy. J. Virol. 75: 8195-8202.
28. Devadas, K., N. J. Hardegen, L. M. Wahl, I. K. Hewlett, K. A. Clouse, K. M. Yamada, and S. Dhawan. 2004. Mechanisms for macrophagc-mediated HIV-1 induction. J. Immunol. 173: 6735-6744.
29. Poli, G., P. Bresslcr, A. Kinter,. E. Duh, W. C. Timmer, A. Rabson, J. S. Justement, S. Stanley, and A. S. Fauci. 1990. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor α by transcriptional and post-transcriptional mechanisms. J. Exp. Med. 172: 151-158.
30. Ray, N., and R. W. Doms. 2006. HIV-1 coreceptors and their inhibitors. Curr. Top. Microbiol. Immunol. 303: 97-120.
31. Shaheen, F., and R. G. Collman. 2004. Co-receptor antagonists as HIV-1 entry inhibitors. Curr. Opin. Infect. Dis. 17: 7-16.
32. Kulkosky, J., and S. Bray. 2006. HAART-persistent HIV-1 latent reservoirs: their origin, mechanisms of stability and potential strategies for eradication. Curr. HIV Res. 4: 199-208.
33. Yang, X., Y. Chen, and D. Gabuzda. 1999. ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-κB. J. Biol. Chem. 274: 27981-27988.
34. Akira, S. 2000. The role of IL-18 in innate immunity. Curr. Opin. Immunol. 12: 59-63.
35. Palanki, M. S. 2002. Inhibitors of AP-1 and NF-κB mediated transcriptional activation: therapeutic potential in autoimmune diseases and structural diversity. Curr. Med. Chem. 9: 219-227.
36. Patterson, B. K., A. Tjernlund, and J. Andersson. 2002. Endogenous inhibitors of HIV: potent anli-HIV activity of leukemia inhibitory factor. Curr. Mol. Med. 2: 713-722.
37. Hussain, M., D. Ni, D. Gill, and M. J. Liao. 2000. IFN-α1 a gene is the major variant in the North American population. J. Interferon Cytokine Res. 20: 763-768.
38. Lallemand, C., P. Lebon, P. Rizza, B. Blanchard, and M. G. Tovey. 1996. Constitutive expression of specific interferon isotypes in peripheral blood leukocytes from normal individuals and in promonocyte U937 cells. J. Leukocyte Biol. 60: 137-146.
39. Locardi, C., C. Petrini, G. Boccoli, U. Testa, C. Dieffenbach, S. Butto, and F. Belardelli. 1990. Increased human immunodeficiency virus (HIV) expression in chronically infected U937 cells upon in vitro differentiation by hydroxyvitamin D3: roles of interferon and tumor necrosis factor in regulation of HIV production. J. Virol. 64: 5874-5882.
40. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R. E. Sutton, C. M. Hill, et al. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381: 661-666.
41. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272: 872-877.
42. Reeves, J. D., and A. J. Piefer. 2005. Emerging drug targets for antiretroviral therapy. Drugs 65: 1747-1766.
43. Genin, P., Y. Mamanc, H. Kwon, C. LePage, M. A. Wainberg, and J. Hiscott. 1999. Differential regulation of CC chemokine gene expression in human immunodeficiency virus-infected myeloid cells. Virology 261: 205-215.
44. Lee, B., B. J. Doranz, S. Rana, Y. Yi, M. Mellado, J. M. Frade, A. C. Martinez, S. J. O'Brien, M. Dean, R. G. Collman, and R. \V. Doms. 1998. Influence of the CCR2-V641 polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4. J. Virol. 72: 7450-7458.
45. Ma, X., and L. J. Montaner. 2000. Proinflammatory response and IL-12 expression in HIV-1 infection. J. Leukocyte Biol. 68: 383-390.
46. Torre, D., and A. Pugliese. 2006. Interleukin-18: a proinflammatory cytokine in HIV-1 infection. Curr. HIV Res. 4: 423-430.
47. Sebastiani, S., C. Albanesi, P. O. De, P. Puddu, A. Cavani, and G. Girolomoni. 2002. The role of chemokines in allergic contact dermatitis. Arch. Dermatol. Res. 293: 552-559.
48. Romagnani, S. 2006. Regulation of the T cell response. Clin. Exp. Allergy 36: 1357-1366.
49. + T cells in vitro. AIDS Res. Hum. Retroviruses 23: 438-450.
50. Holmes, D., G. Knudsen, S. Mackey-Cushman, and L. Su. 2007. FoxP3 enhances HIV-1 gene expression by modulating NFκB occupancy at the long terminal repeat in human T cells. J. Biol. Chem. 282: 15973-15980.